Literature DB >> 34047193

Cemiplimab: a new option for the treatment of non-small-cell lung cancer.

Nadine Khalife1, Manal Kordahi2, Tony Felefly3, Khalil Saleh4.   

Abstract

Entities:  

Keywords:  PD-L1; atezolizumab; brain metastases; cemiplimab; non-small-cell lung cancer; pembrolizumab

Year:  2021        PMID: 34047193     DOI: 10.2217/fon-2021-0343

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  1 in total

Review 1.  Biomarkers of response to checkpoint inhibitors beyond PD-L1 in lung cancer.

Authors:  Lynette M Sholl
Journal:  Mod Pathol       Date:  2021-10-04       Impact factor: 7.842

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.